News

@Pharmacy_Times
pharmacytimes.com > view > study-finds-statistically-significant-risk-of-developing-ckd-eskd-following-preeclampsia

Study Finds Statistically Significant Risk of Developing CKD, ESKD Following Preeclampsia

Study Finds Statistically Significant Risk of Developing CKD, ESKD Following Preeclampsia24+ min ago   (422+ words) Preeclampsia significantly raises the risk of chronic kidney disease (CKD) later in life, highlighting the need for targeted postpartum monitoring for affected women. Prior to delivery, preeclampsia treatment includes careful monitoring and medications to lower blood pressure and manage complications....

@Pharmacy_Times
pharmacytimes.com > view > fda-finds-no-increased-suicide-risk-with-glp-1-medications-requests-removal-of-warning-labels

FDA Finds No Increased Suicide Risk With GLP-1 Medications, Requests Removal of Warning Labels

FDA Finds No Increased Suicide Risk With GLP-1 Medications, Requests Removal of Warning Labels1+ hour, 5+ min ago   (552+ words) GLP-1s are primarily used to manage type 2 diabetes (T2D) and obesity and have demonstrated tolerable efficacy and safety profiles across numerous studies. These medications help lower blood glucose levels and act in parts of the brain that control appetite and food…...

@Pharmacy_Times
pharmacytimes.com > view > financial-assistance-versus-copay-accumulators-protecting-patients-from-cost-shock

Financial Assistance Versus Copay Accumulators: Protecting Patients from Cost Shock

Financial Assistance Versus Copay Accumulators: Protecting Patients from Cost Shock1+ hour, 45+ min ago   (556+ words) High out-of-pocket costs lead patients to skip medications. Financial assistance programs improve adherence, but complex insurance strategies may hinder access. High out-of-pocket costs push many adults to skip doses of their medication, split tablets, or abandon new prescriptions. Cost conversations…...

@Pharmacy_Times
pharmacytimes.com > view > phase-3-majestec-9-trial-shows-survival-benefit-with-teclistamab-in-multiple-myeloma

Phase 3 MajesTEC-9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma

Phase 3 MajesTEC-9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma19+ hour, 4+ min ago   (699+ words) Topline results from a new drug trial show that teclistamab-cqyv (Tecvayli; Janssen Biotech) monotherapy offers significant survival benefits for patients with multiple myeloma (MM). In the phase 3 randomized MajesTEC-9 study (NCT05572515), teclistamab-cqyv showed a 71% reduction in the risk of disease progression or…...

@Pharmacy_Times
pharmacytimes.com > view > fda-notifies-flu-vaccine-makers-to-add-warning-for-increased-febrile-seizure-risk-in-young-children-day-following-vaccination

FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination

FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination1+ day, 12+ hour ago   (426+ words) According to the news release, the manufacturers have 30 days to respond....

@Pharmacy_Times
pharmacytimes.com > view > shingles-vaccination-lowers-risk-of-heart-disease-dementia-and-death-in-older-adults

Shingles Vaccination Lowers Risk of Heart Disease, Dementia, and Death in Older Adults

Shingles Vaccination Lowers Risk of Heart Disease, Dementia, and Death in Older Adults2+ day, 9+ hour ago   (618+ words) Recombinant zoster vaccination against shingles was found to significantly reduce the risk of heart disease and dementia, even after a prior case of shingles. Recombinant zoster vaccination (RZV) against herpes zoster (shingles) can reduce the risk of heart disease, dementia,…...

@Pharmacy_Times
pharmacytimes.com > view > expert-highlights-patient-centered-advantages-of-bispecific-antibody-therapy

Expert Highlights Patient-Centered Advantages of Bispecific Antibody Therapy

Expert Highlights Patient-Centered Advantages of Bispecific Antibody Therapy2+ day, 14+ hour ago   (506+ words) From a patient perspective, she highlighted the high response rates achieved without the use of traditional chemotherapy, which can often be associated with significant toxicity and treatment burden. The chemo-free nature of epcoritamab offers an appealing alternative for patients who…...

@Pharmacy_Times
pharmacytimes.com > view > study-shows-pitavastatin-could-be-a-promising-therapy-for-triple-negative-breast-cancer

Study Shows Pitavastatin Could be a Promising Therapy for Triple-Negative Breast Cancer

Study Shows Pitavastatin Could be a Promising Therapy for Triple-Negative Breast Cancer3+ day, 9+ hour ago   (558+ words) Pitavastatin shows promise as a novel treatment for triple-negative breast cancer, enhancing chemotherapy efficacy and targeting cancer cell survival pathways. The development of new and effective therapies is necessary, especially for those who are capable of counteracting chemoresistance and targeting…...

@Pharmacy_Times
pharmacytimes.com > view > study-pharmacists-female-pharmacy-technicians-at-a-higher-risk-of-suicide-than-general-population

Study: Pharmacists, Female Pharmacy Technicians at a Higher Risk of Suicide Than General Population

Study: Pharmacists, Female Pharmacy Technicians at a Higher Risk of Suicide Than General Population3+ day, 10+ hour ago   (480+ words) The findings reemphasize a need for mental health support for those in the pharmacy profession. "Employers must create environments where taking time for mental health is normalized and supported. It shouldn't be difficult for someone to seek help," Lee urged....

@Pharmacy_Times
pharmacytimes.com > view > pharmacists-face-new-challenges-under-updated-hhs-vaccine-guidance

Pharmacists Face New Challenges Under Updated HHS Vaccine Guidance

Pharmacists Face New Challenges Under Updated HHS Vaccine Guidance3+ day, 13+ hour ago   (473+ words) Jeffery A. Goad, PharmD, MPH, explains how the shift toward shared clinical decision-making for pediatric vaccines may complicate counseling, reduce vaccine uptake, and increase public health risks. Ultimately, Goad warned that families who rely most on pharmacy access'those facing language barriers,…...